Series A
$4m
Cannabis startup CannVaLate raises $4 million in seven days in oversubscribed Series A, just six months after launch
Medicinal cannabis platform CannVaLate oversubscribed its Series A within a week, collecting $4 million largely from doctor investors, six months after launching, with funds spent on licensing and technology and a Series B planned.